90% of injection drug users miss opportunities for HIV or HCV testing

Using data from more than 840,000 health care encounters, researchers estimated that around 90% of people who inject drugs missed opportunities for HIV or hepatitis C virus testing during a recent 8-year period — especially rural males seeking care for skin infections or endocarditis.
“We were interested in assessing HIV and hepatitis C infection testing rates for patients with substance use disorders, and in understanding opportunities for increasing testing rates at clinical visits,” Lara Bull-Otterson, PhD, MPH, an epidemiologist in the CDC’s National Center for

Source link

Related posts

Recommendations Provided for Treatment of Ulcerative Colitis


UCSF, Stanford receive $35M to further research of microbiome


Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy